1 Introduction
2 Methods
2.1 Data source
2.2 Study population
2.3 Protocol for analysis of AF alerts
2.4 Classification of device type
2.5 AF episode duration
2.6 Classification of stroke risk
2.7 System prompts for anticoagulation and classification of anticoagulation status
2.8 Statistical analysis
3 Results
3.1 AF alert cohort
Device type | Number (%) | Average age (years) |
---|---|---|
PPM | 3436 (44.9) | 77 ± 11 |
Dual-chamber PPM | 3120 (40.8) | 77 ± 11 |
CRT-P | 316 (4.1) | 78 ± 12 |
ICD | 1955 (25.6) | 71 ± 12 |
Dual-chamber ICD | 987 (12.9) | 70 ± 12 |
CRT-D | 968 (12.7) | 73 ± 12 |
ILR | 2260 (29.5) | 70 ± 12 |
All devices | 7651 (100) | 74 ± 12 |
3.2 Device manufacturers
Device type | Device manufacturer | n (%) |
---|---|---|
PPM | Medtronic | 1807 |
Boston Scientific | 1168 | |
St. Jude Medical (Abbott) | 150 | |
Biotronik | 311 | |
ICD | Medtronic | 826 |
Boston Scientific | 833 | |
St. Jude Medical (Abbott) | 140 | |
Biotronik | 156 | |
ILR | Medtronic | 1660 |
St. Jude Medical (Abbott) | 585 | |
Biotronik | 15 | |
All CIEDs | Medtronic | 4293 (56.1) |
Boston Scientific | 2001 (26.2) | |
St. Jude Medical (Abbott) | 875 (11.4) | |
Biotronik | 482 (6.3) |
3.3 AF episode duration
3.4 Anticoagulation rates in patients aged ≥ 75 years (minimum CHA2DS2-VASc score of 2) with AF episode at least 6 h in duration
3.5 Anticoagulation rates in patients aged 65–74 years with AF episodes at least 6 h in duration
3.6 Comparison of anticoagulation rates across patient age groups
4 Discussion
4.1 Major findings
-
• AF episode burden was significant across all device types; however, there was an over-representation of AF episodes detected by ILRs
-
• A substantial proportion of patients with a significant risk of ischemic stroke as indicated by their AF episode duration combined with their CHA2DS2-VASc score remain not anticoagulated
-
• Anticoagulation rates among older patients were comparatively lower than rates among younger patients